Meiji Yasuda Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.2M | Sell |
6,392
-6,769
| -51% | -$3.25M | 0.14% | 178 |
|
|
2026
Q1 | $6.47M | Sell |
13,161
-516
| -4% | -$280K | 0.32% | 93 |
|
|
2025
Q4 | $7.93M | Sell |
13,677
-933
| -6% | -$528K | 0.38% | 64 |
|
|
2025
Q3 | $7.09M | Sell |
14,610
-478
| -3% | -$222K | 0.34% | 84 |
|
|
2025
Q2 | $6.12M | Sell |
15,088
-5,078
| -25% | -$2.12M | 0.3% | 100 |
|
|
2025
Q1 | $10M | Sell |
20,166
-463
| -2% | -$251K | 0.4% | 56 |
|
|
2024
Q4 | $10.7M | Buy |
20,629
+88
| +0.4% | +$48.4K | 0.41% | 58 |
|
|
2024
Q3 | $12.7M | Buy |
20,541
+19
| +0.1% | +$11.2K | 0.48% | 45 |
|
|
2024
Q2 | $11.3M | Buy |
20,522
+1,247
| +6% | +$714K | 0.46% | 49 |
|
|
2024
Q1 | $11.2M | Buy |
19,275
+907
| +5% | +$509K | 0.48% | 48 |
|
|
2023
Q4 | $9.75M | Sell |
18,368
-679
| -4% | -$329K | 0.44% | 60 |
|
|
2023
Q3 | $9.64M | Buy |
19,047
+1,675
| +10% | +$893K | 0.45% | 59 |
|
|
2023
Q2 | $9.06M | Sell |
17,372
-477
| -3% | -$257K | 0.45% | 62 |
|
|
2023
Q1 | $10.3M | Buy |
17,849
+1,012
| +6% | +$570K | 0.53% | 47 |
|
|
2022
Q4 | $9.27K | Buy |
16,837
+142
| +0.9% | +$75.2K | 0.44% | 59 |
|
|
2022
Q3 | $8.47M | Sell |
16,695
-912
| -5% | -$510K | 0.49% | 45 |
|
|
2022
Q2 | $9.57M | Buy |
17,607
+295
| +2% | +$162K | 0.56% | 36 |
|
|
2022
Q1 | $10.2M | Sell |
17,312
-2,270
| -12% | -$1.3M | 0.56% | 38 |
|
|
2021
Q4 | $13.1M | Buy |
19,582
+1,853
| +10% | +$1.16M | 0.81% | 23 |
|
|
2021
Q3 | $10.1M | Sell |
17,729
-55,810
| -76% | -$30.6M | 0.72% | 26 |
|
|
2021
Q2 | $37.1M | Buy |
73,539
+52,170
| +244% | +$24.6M | 1.76% | 8 |
|
|
2021
Q1 | $9.75M | Buy |
21,369
+345
| +2% | +$165K | 0.72% | 26 |
|
|
2020
Q4 | $9.79M | Sell |
21,024
-3,631
| -15% | -$1.7M | 0.97% | 21 |
|
|
2020
Q3 | $10.9M | Sell |
24,655
-3,040
| -11% | -$1.26M | 1.2% | 16 |
|
|
2020
Q2 | $10M | Buy |
27,695
+2,659
| +11% | +$891K | 0.95% | 18 |
|
|
2020
Q1 | $7.1M | Sell |
25,036
-2,845
| -10% | -$897K | 1.34% | 13 |
|
|
2019
Q4 | $9.06M | Sell |
27,881
-5,090
| -15% | -$1.54M | 0.76% | 23 |
|
|
2019
Q3 | $9.6M | Buy |
32,971
+1,343
| +4% | +$385K | 0.78% | 25 |
|
|
2019
Q2 | $9.29M | Sell |
31,628
-5,144
| -14% | -$1.42M | 0.78% | 26 |
|
|
2019
Q1 | $10.1M | Sell |
36,772
-174
| -0.5% | -$43.3K | 0.85% | 20 |
|
|
2018
Q4 | $8.27M | Sell |
36,946
-503
| -1% | -$118K | 0.77% | 23 |
|
|
2018
Q3 | $9.14M | Buy |
37,449
+1,280
| +4% | +$294K | 0.74% | 25 |
|
|
2018
Q2 | $7.49M | Buy |
36,169
+1,670
| +5% | +$354K | 0.67% | 31 |
|
|
2018
Q1 | $7.12M | Buy |
34,499
+1,013
| +3% | +$213K | 0.68% | 30 |
|
|
2017
Q4 | $6.36M | Sell |
33,486
-2,144
| -6% | -$411K | 0.61% | 40 |
|
|
2017
Q3 | $6.74M | Buy |
35,630
+300
| +0.8% | +$54.3K | 0.66% | 31 |
|
|
2017
Q2 | $6.16M | Sell |
35,330
-415
| -1% | -$69.7K | 0.63% | 37 |
|
|
2017
Q1 | $5.49M | Buy |
35,745
+2,522
| +8% | +$385K | 0.59% | 39 |
|
|
2016
Q4 | $4.69M | Sell |
33,223
-1,495
| -4% | -$220K | 0.52% | 52 |
|
|
2016
Q3 | $5.52M | Buy |
34,718
+1,481
| +4% | +$228K | 0.65% | 33 |
|
|
2016
Q2 | $4.91M | Buy |
33,237
+5,777
| +21% | +$853K | 0.7% | 33 |
|
|
2016
Q1 | $3.89M | Buy |
27,460
+455
| +2% | +$61K | 0.88% | 28 |
|
|
2015
Q4 | $3.83M | Buy |
27,005
+1,327
| +5% | +$177K | 0.87% | 29 |
|
|
2015
Q3 | $3.14M | Buy |
25,678
+695
| +3% | +$90.5K | 0.77% | 38 |
|
|
2015
Q2 | $3.24M | Buy |
24,983
+2,222
| +10% | +$290K | 0.76% | 37 |
|
|
2015
Q1 | $3.06M | Buy |
22,761
+2,427
| +12% | +$313K | 0.74% | 41 |
|
|
2014
Q4 | $2.55M | Sell |
20,334
-2,766
| -12% | -$336K | 0.61% | 48 |
|
|
2014
Q3 | $2.81M | Sell |
23,100
-4,992
| -18% | -$607K | 0.66% | 46 |
|
|
2014
Q2 | $3.31M | Buy |
28,092
+488
| +2% | +$57.4K | 0.68% | 48 |
|
|
2014
Q1 | $3.32M | Sell |
27,604
-3,630
| -12% | -$432K | 0.72% | 44 |
|
|
2013
Q4 | $3.48M | Sell |
31,234
-2,508
| -7% | -$249K | 0.73% | 45 |
|
|
2013
Q3 | $3.11M | Sell |
33,742
-2,051
| -6% | -$185K | 0.7% | 50 |
|
|
2013
Q2 | $3.04M | Buy |
+35,793
| New | +$2.98M | 0.72% | 42 |
|
Other funds holding TMO
Meiji Yasuda Asset Management's TMO Position: Q2 2026 in Review
Meiji Yasuda Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 51% in Q2 2026, selling an estimated $3.25M and leaving 6,392 shares worth $3.2M. The position accounts for 0.14% of the portfolio, ranked #178.
Meiji Yasuda Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.1M in Q2 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Meiji Yasuda Asset Management held 6,392 shares of Thermo Fisher Scientific worth $3.2M as of Q2 2026.
- Meiji Yasuda Asset Management sold 6,769 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.25M.
- Thermo Fisher Scientific made up 0.14% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #178 holding.
- Meiji Yasuda Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Meiji Yasuda Asset Management's Thermo Fisher Scientific position peaked at $37.1M in Q2 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.